ORIAW
Orion Biotech Opportunities Corp. Warrant
ORIAW
ORIAW
Delisted
ORIAW was delisted on the 28th of April, 2023.
30 hedge funds and large institutions have $2.63M invested in Orion Biotech Opportunities Corp. Warrant in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
30
Holding in Top 10
–
Calls
$557K
Puts
–
Top Buyers
| 1 | +$54K | |
| 2 | +$37K | |
| 3 | +$37K | |
| 4 |
CCM
Context Capital Management
Lajolla,
California
|
+$16K |
| 5 |
CAC
Cowen and Company
New York
|
+$10K |
Top Sellers
| 1 | -$28K | |
| 2 | -$9.71K | |
| 3 | -$4K | |
| 4 |
DCM
DG Capital Management
New York
|
-$3.34K |
| 5 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$3.2K |